|
Re: Phase 1b/2 trial expected to initiate 1Q 2019
|
3
|
Zenith Epigenetics
|
Mar 06, 2019 03:04PM
|
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
5
|
Resverlogix Corp.
|
Jan 28, 2019 09:23AM
|
|
Re: Phase III - Where will it take place
|
|
Resverlogix Corp.
|
Sep 07, 2015 08:14PM
|
|
Re: Pipeline
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 23, 2021 09:49AM
|
|
Re: Pipeline
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 23, 2021 10:26AM
|
|
Re: Placebo or Standard of Care
|
3
|
Resverlogix Corp.
|
Nov 02, 2019 10:14AM
|
|
Re: Positive determination....
|
|
Resverlogix Corp.
|
Oct 31, 2016 09:36PM
|
|
Re: Positive spin anyone?
|
5
|
Resverlogix Corp.
|
May 30, 2018 03:05PM
|
|
Re: Possibile deals for both RVX and Zenith
|
8
|
Resverlogix Corp.
|
Oct 17, 2017 08:25PM
|
|
Re: Potential
|
3
|
Zenith Epigenetics
|
Jul 20, 2021 03:53PM
|
|
Re: Potential Suitor
|
4
|
Resverlogix Corp.
|
Sep 12, 2020 06:09PM
|
|
Re: Potential Suitor
|
3
|
Resverlogix Corp.
|
Sep 13, 2020 08:33AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
|
Resverlogix Corp.
|
Jan 10, 2018 08:43AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
|
Resverlogix Corp.
|
Jan 10, 2018 08:46AM
|
|
Re: Precedence in Gene Therapy Pricing
|
2
|
Resverlogix Corp.
|
Jan 03, 2018 03:50PM
|
|
Re: Precedence in Gene Therapy Pricing
|
1
|
Resverlogix Corp.
|
Jan 03, 2018 04:03PM
|
|
Re: Precedence in Gene Therapy Pricing
|
1
|
Resverlogix Corp.
|
Jan 04, 2018 08:00AM
|
|
Re: Precedence in Gene Therapy Pricing
|
|
Resverlogix Corp.
|
Jan 04, 2018 08:27AM
|
|
Re: Precedence in Gene Therapy Pricing
|
3
|
Resverlogix Corp.
|
Jan 04, 2018 08:55AM
|
|
Re: Predictions ......
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 06:18AM
|
